BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29965975)

  • 1. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
    Ismail A; Tabu C; Onuekwusi I; Otieno SK; Ademba P; Kamau P; Koki B; Ngatia A; Wainaina A; Davis R
    Pan Afr Med J; 2017; 27(Suppl 3):16. PubMed ID: 29296151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster survey evaluation of a measles vaccination campaign in Jharkhand, India, 2012.
    Scobie HM; Ray A; Routray S; Bose A; Bahl S; Sosler S; Wannemuehler K; Kumar R; Haldar P; Anand A
    PLoS One; 2015; 10(5):e0127105. PubMed ID: 26010084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
    BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
    Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
    Danovaro-Holliday MC; Rhoda DA; Lacoul M; Prier ML; Gautam JS; Pokhrel TN; Dixit SM; Rajbhandari RM; Bose AS
    BMC Public Health; 2022 Feb; 22(1):221. PubMed ID: 35114969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET
    J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: A cross-sectional study.
    Rajkumari B; Keisam A; Haobam DS; Thounaojam T
    Indian J Public Health; 2020; 64(2):173-177. PubMed ID: 32584301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting non-coverage of measles-rubella vaccination among children aged 9-59 months in Tanzania.
    Mkopi A; Mtenga S; Festo C; Mhalu G; Shabani J; Tillya R; Masemo A; Kheir K; Nassor M; Mwengee W; Lyimo D; Masanja H
    Vaccine; 2021 Oct; 39(41):6041-6049. PubMed ID: 34531077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
    Abd Elaziz KM; Sabbour SM; Dewedar SA
    Vaccine; 2010 Nov; 28(47):7563-8. PubMed ID: 20797454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
    Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K
    Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
    Thangaraj JWV; Prosperi C; Kumar MS; Hasan AZ; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sarmah NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murherkar MV
    PLoS One; 2024; 19(3):e0297385. PubMed ID: 38551928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
    J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.